- Created: 30-04-18
Monty Karl advertisements
Description: Drug formulation 2017 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Seoul, South Korea . We are delighted to invite you all to attend and register for the “9th Annual Congress on Drug Formulation & Drug Design” (Drug formulation 2017) which is going to be held during October 19-20, 2017 at Seoul, South Korea. We invite you to join us at the Drug Formulation 2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2017 organizing committee look forward to meeting you in Seoul, South Korea . Drug Design is the inventive process of finding new medications based on the knowledge of a biological target. Drug Formulation is a process in Pharmaceutics. Formulation means compounding of single or combination of active ingredients, excipients like Fillers, Disintegrants, Lubricants, Glidants, and Binders etc., packed in a single pack to form a Pharmaceutical Drug. Formulation deals with Active Pharmaceutical Ingredient to Packaging of the finished product which means Analytical R & D, Formulation R & D, Blending, Drying, Punching or Filling, Packaging. Formulation may be in different dosage forms like Oral Dosage Forms, Parenteral Dosage Forms and Topical Dosage Forms. Pharmaceutical formulation is the development of a bioavailable, stable and optimal dosage form for a specific administration route.
Publish Date: 22-07-17
Description: Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07, 2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China. Why China? China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its market value could reach more than $158bn in 2016, and expand strongly to 2023. Conference Highlights: • Preformulation • Formulation • Drug Formulation Procedures • Drug Delivery System • Stability Studies • Drug Product Manufacturing • Analytical Method Development • Medicinal chemistry • Biopharmaceutics Classification System • Bioavailability Studies • Factors Affecting Bioavailability • Nutrient bioavailability • Advances in Bioavailability • Traditional Medicine • Clinical Studies • Regulatory & Quality Management Support
Publish Date: 02-01-16